Literature DB >> 1672684

Evoked potential topography in unmedicated and medicated schizophrenics.

C Shagass1, R Roemer.   

Abstract

The main purposes were to determine whether: (1) evoked potential (EP) topography differs from normal in schizophrenics; (2) EP topography is altered by psychotropic drugs. Unmedicated (n = 72) and medicated (n = 57) schizophrenics were compared with age- and sex-matched non-patients and with one another. EPs to left and right median nerve, visual pattern and auditory stimuli were recorded from 15 leads. EP data were reduced by principal component analysis (PCA) of EP waveforms, with separate PCAs for later and earlier poststimulus times; 32 factors were extracted. Factor scores, based on factor structure of 195 non-patients, were computed for all subjects. Topographic effects were evaluated by ANOVAs on Z-transformed factor scores. The results were: (1) topographies differed between groups in about one-third of the factors, but variables yielding effects differed between comparisons; (2) topographic differences from normal in unmedicated patients converged at left temporoparietal (higher in schizophrenics) and right fronto-central-temporal areas (lower in schizophrenics); (3) similar convergence was absent in medicated patients; (4) most medicated vs unmedicated patient topographic differences persisted in groups matched for psychopathology. Results appear consistent with "focal cortical arousal" of the left posterior quadrant in schizophrenics (Morihisa and Duffy, 1986) and suggest that medication alters EP topography.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672684     DOI: 10.1016/0167-8760(91)90031-r

Source DB:  PubMed          Journal:  Int J Psychophysiol        ISSN: 0167-8760            Impact factor:   2.997


  3 in total

1.  Associative process as an indicator of interhemispheric interaction in healthy children and children with autism.

Authors:  N N Nikolaenko
Journal:  Dokl Biol Sci       Date:  2001 Sep-Oct

2.  31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms.

Authors:  H Fukuzako; K Takeuchi; K Ueyama; T Fukuzako; Y Hokazono; K Hirakawa; K Yamada; T Hashiguchi; M Takigawa; T Fujimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

3.  Computational Modeling of Contrast Sensitivity and Orientation Tuning in First-Episode and Chronic Schizophrenia.

Authors:  Steven M Silverstein; Docia L Demmin; James A Bednar
Journal:  Comput Psychiatr       Date:  2017-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.